Top compounds associated with response to SYT17


Feature Type Standardized
Nominal ANOVA
mRNA ML203 CTRPv2 pan-cancer AAC 0.12 0.002
mRNA Cytarabine GDSC1000 pan-cancer AAC -0.12 0.002
mRNA Erlotinib CCLE pan-cancer AAC 0.15 0.002
mRNA BRD-K45681478 CTRPv2 pan-cancer AAC 0.12 0.002
mRNA BRD-K63431240 CTRPv2 pan-cancer AAC -0.11 0.003
mRNA JQ-1 GDSC1000 pan-cancer AAC -0.11 0.003
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.003
mRNA necrostatin-7 CTRPv2 pan-cancer AAC 0.12 0.003
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.003
mRNA Vinblastine GDSC1000 pan-cancer AAC -0.11 0.003
Download CSV